Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes
暂无分享,去创建一个
G. Velho | M. Marre | G. Velho | L. Canani | M. Côrrea-Giannella | K. Mohammedi | M. Azevedo | M. Marre | M. Queiroz | M. B. Monteiro | L. H. Canani | M. B. Monteiro | T. A. Patente | K. Mohammedi | M. S. Queiroz | M. J. Azevedo | M. C. Parisi | M. L. Corrêa-Giannella | T. Patente | K. Mohammedi | M. Parisi | M. L. Correa-Giannella | Luis Henrique Santos Canani | M. J. Azevedo | Maria Candida Ribeiro Parisi | Gilberto Velho | Michel Marre | Márcia Silva Queiroz
[1] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[2] R. Brigelius-Flohé,et al. Glutathione peroxidases. , 2013, Biochimica et biophysica acta.
[3] M. Silvestrini,et al. Oxidative stress in ischaemic stroke , 2011, European journal of clinical investigation.
[4] A. Reddi,et al. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats. , 2001, Kidney international.
[5] C. Boland,et al. Oxidative stress increases frameshift mutations in human colorectal cancer cells. , 2001, Cancer research.
[6] G. Bernardi,et al. Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. , 2009, International review of neurobiology.
[7] S. D. Pena,et al. Color and Genomic Ancestry in Brazilians: A Study with Forensic Microsatellites , 2006, Human Heredity.
[8] G. Sadi,et al. Changes in expression profiles of antioxidant enzymes in diabetic rat kidneys , 2012, Diabetes/metabolism research and reviews.
[9] R. Atkins,et al. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. , 2005, American journal of physiology. Renal physiology.
[10] S. Rich. Genetics of diabetes and its complications. , 2006, Journal of the American Society of Nephrology : JASN.
[11] R. Brigelius-Flohé. Tissue-specific functions of individual glutathione peroxidases. , 1999, Free radical biology & medicine.
[12] T. Illig,et al. The C718T polymorphism in the 3′-untranslated region of glutathione peroxidase-4 gene is a predictor of cerebral stroke in patients with essential hypertension , 2012, Hypertension Research.
[13] A. Alegría,et al. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. , 1998, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[14] H. Nawata,et al. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment , 2003, Diabetologia.
[15] J. Kyle,et al. A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. , 2002, Blood cells, molecules & diseases.
[16] J. Mathers,et al. Evidence that a polymorphism within the 3′UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer , 2007, Genes & Nutrition.
[17] A. Demaine,et al. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. , 2003, Diabetes care.
[18] C. Wilcox,et al. NADPH oxidases in the kidney. , 2006, Antioxidants & redox signaling.
[19] S. Hadjadj,et al. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. , 2011, Molecular genetics and metabolism.
[20] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[21] E. Flagg,et al. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. , 1998, Free radical biology & medicine.
[22] M. Berry,et al. Regulation and function of selenoproteins in human disease. , 2009, The Biochemical journal.
[23] S. Chanock,et al. CYBB, an NADPH‐oxidase gene: restricted diversity in humans and evidence for differential long‐term purifying selection on transmembrane and cytosolic domains , 2008, Human mutation.
[24] J. Mathers,et al. Functional effects of a common single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene: interaction with sex. , 2008, The American journal of clinical nutrition.
[25] B. Lell,et al. DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. , 2004, The Journal of infectious diseases.
[26] E. Tarazona-Santos,et al. Characterization of a candidate locus for malaria susceptibility in human populations: a (TA)n microsatellite in the promoter region of the CYBB gene, the gp91phox subunit of the NADPH oxidase , 2008, International journal of immunogenetics.
[27] V. Rigalleau,et al. Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. , 2004, Diabetes care.
[28] P. Whelton,et al. Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. , 2010, American journal of hypertension.
[29] Yoav Gilad,et al. Sex-specific genetic architecture of human disease , 2008, Nature Reviews Genetics.
[30] B. Ames,et al. Adaptive dysfunction of selenoproteins from the perspective of the triage theory: why modest selenium deficiency may increase risk of diseases of aging , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] J. Hesketh,et al. Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. , 1995, The Biochemical journal.
[32] R. Bostick,et al. A summary measure of pro- and anti-oxidant exposures and risk of incident, sporadic, colorectal adenomas , 2008, Cancer Causes & Control.
[33] G Chatellier,et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.
[34] Maristela L Onozato,et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. , 2005, Kidney international.
[35] S. Dib,et al. Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus , 2011, BMC Medical Genetics.
[36] P Griffiths,et al. Mice with a Homozygous Null Mutation for the Most Abundant Glutathione Peroxidase, Gpx1, Show Increased Susceptibility to the Oxidative Stress-inducing Agents Paraquat and Hydrogen Peroxide* , 1998, The Journal of Biological Chemistry.
[37] J. Doroshow,et al. Role of the glutathione-glutathione peroxidase cycle in the cytotoxicity of the anticancer quinones. , 1990, Pharmacology & therapeutics.
[38] K. Krause,et al. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.
[40] A. Doria. Genetics of Diabetes Complications , 2010, Current diabetes reports.
[41] H. Gautrey,et al. A T/C polymorphism in the GPX4 3′UTR affects the selenoprotein expression pattern and cell viability in transfected Caco-2 cells , 2011, Biochimica et biophysica acta.